Notice of Correction to Table of Page Limits and change to Receipt Date for RFA-NS-24-011 "Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional)"
Notice Number:
NOT-NS-24-011

Key Dates

Release Date:

August 31, 2023

Related Announcements

  • May 4, 2023 - Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional). See RFA-NS-24-011.

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to notify applicants of a correction to the table of page limits and Instructions for Submission of Multi-component Applications for RFA-NS-24-011 "Center without Walls for PET Ligand Development for Alzheimer's disease-related dementias (ADRDs) (U19 - Clinical Trial Optional)". The Table of Page Limits has been revised to show that the Admin Core is required and a maximum of one Admin Core is Allowed. Additionally, the table has been revised to show that there is a maximum of one Clinical Core and Medicinal Chemistry Core allowed. A summary list has also been added to the Instructions for the Submission of Multi-Component Applications. Lastly, the receipt date has been moved to October 3, 2023 and the expiration date has been moved to October 4, 2023 to allow applicants more time to apply. Changes to the notice of funding opportunity (NOFO) are shown below.

Currently Reads:

Part 1. Overview Information

Key Dates

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDSScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
September 26, 2023September 26, 2023Not ApplicableMarch 2024May 2024July 2024

Expiration Date:  September 27, 2023

Section IV. Application and Submission Information

2. Content and Form of Application Submission

Page Limitations

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

ComponentComponent Type for SubmissionPage LimitRequired/OptionalMinimumMaximum
OverallOverall12Required11
Admin CoreAdmin Core6Required1$multicomponent.maxInstances
Medicinal ChemistryMedicinal Chemistry6Required1NA
Clinical CoreClinical Core6Required1NA
ProjectProject12Required2NA

 











 

Instructions for the Submission of Multi-Component Applications

The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing a multi-component application.

Modified to Read:

Part 1. Overview Information

Key Dates

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDSScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
October 3, 2023October 3, 2023Not ApplicableMarch 2024May 2024July 2024

 

Expiration Date: October 4, 2023

IV. Application and Submission Information

2. Content and Form of Application Submission

Page Limitations

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

ComponentComponent Type for SubmissionPage LimitRequired/OptionalMinimumMaximum
OverallOverall12Required11
Admin CoreAdmin Core6Required11
Medicinal ChemistryMedicinal Chemistry6Required11
Clinical CoreClinical Core6Required11
ProjectProject12Required2NA














Instructions for the Submission of Multi-Component Applications

The following section supplements the instructions found in the SF424 (R&R) Application Guide and should be used for preparing a multi-component application.

  • Overall: required, maximum of 1
  • Administrative (Admin Core): required, maximum of 1
  • Medicinal Chemistry: required, maximum of 1
  • Clinical Core: required, maximum of 1
  • Projects: required, minimum of 2

All other aspects of this NOFO remain unchanged.

Inquiries

Please direct all inquiries to:

Debra Babcock, PhD, MD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9964
Email: [email protected]